Cas:917023-06-4 Methyl 2-(5-bromopyridin-2-yl)acetate manufacturer & supplier

We serve Chemical Name:Methyl 2-(5-bromopyridin-2-yl)acetate CAS:917023-06-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 2-(5-bromopyridin-2-yl)acetate

Chemical Name:Methyl 2-(5-bromopyridin-2-yl)acetate
CAS.NO:917023-06-4
Synonyms:Methyl (5-bromo-2-pyridinyl)acetate;2-Pyridineacetic acid, 5-bromo-, methyl ester;(5-bromo-pyridin-2-yl)-acetic acid methyl ester;(5-bromo-2-pyridinyl)-acetic acid methyl ester;methyl 5-bromopyridine-2-acetate
Molecular Formula:C8H8BrNO2
Molecular Weight:230.059
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:266.0±25.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.546
PSA:39.19000
Exact Mass:228.973831
LogP:1.50

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl (5-bromo-2-pyridinyl)acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 5-bromopyridine-2-acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5-bromo-2-pyridinyl)-acetic acid methyl ester Use and application,Methyl (5-bromo-2-pyridinyl)acetate technical grade,usp/ep/jp grade.


Related News: That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. Methyl 2-(5-bromopyridin-2-yl)acetate manufacturer One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. Methyl 2-(5-bromopyridin-2-yl)acetate supplier The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market. Methyl 2-(5-bromopyridin-2-yl)acetate vendor But Sanofi’s rival CD38 antibody Sarclisa may soon be able to challenge Darzalex in the same front-line, transplant-ineligible population with the help of a more powerful backbone. Methyl 2-(5-bromopyridin-2-yl)acetate factory The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.